Berretta, Massimiliano; Bignucolo, Alessia; Francia, Raffaele Di; Comello, Francesco; Facchini, Gaetano; Ceccarelli, Manuela; Iaffaioli, Rosario Vincenzo; Quagliariello, Vincenzo; Maurea, Nicola published the artcile< Resveratrol in cancer patients: from bench to bedside>, Electric Literature of 501-36-0, the main research area is review pharmacokinetics resveratrol cardioprotectant anticancer agent cardiovascular disease cancer; cancer; complementary medicines; cytochrome P450; food-drug; inflammation; personalized medicine; pharmacodynamic; pharmacokinetic; resveratrol.
A review. Resveratrol (3,5,4′-trihydroxystilbene) is a natural phytoalexin that accumulates in several vegetables and fruits like nuts, grapes, apples, red fruits, black olives, capers, red rice as well as red wines. Being both an extremely reactive mol. and capable to interact with cytoplasmic and nuclear proteins in human cells, resveratrol has been studied over the years as complementary and alternative medicine (CAM) for the therapy of cancer, metabolic and cardiovascular diseases like myocardial ischemia, myocarditis, cardiac hypertrophy and heart failure. This review will describe the main biol. targets, cardiovascular outcomes, physico-chem. and pharmacokinetic properties of resveratrol in preclin. and clin. models implementing its potential use in cancer patients.
International Journal of Molecular Sciences published new progress about Antitumor agents. 501-36-0 belongs to class alcohols-buliding-blocks, and the molecular formula is C14H12O3, Electric Literature of 501-36-0.
Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts